表紙
市場調査レポート

世界のポイントオブケア(POC)臨床化学・免疫診断検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境

2016-2020 New Frontiers in the Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

発行 Venture Planning Group 商品コード 304985
出版日 ページ情報 英文 500 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

Local License: 同一事業所内

Back to Top
世界のポイントオブケア(POC)臨床化学・免疫診断検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境 2016-2020 New Frontiers in the Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape
出版日: ページ情報: 英文 500 Pages
概要

当レポートでは、世界の主要国(米国・ドイツ・スペイン)におけるポイントオブケア(POC)向け臨床化学・免疫診断検査関連の市場の現状・将来展望について分析し、関連技術および市場(検査試薬・試薬など)の最新状況や、国別・部門別の市場規模および成長率(今後5年間分)、規制環境、競争構造、今後の需要・技術活用方法の方向性、主要企業のプロファイルなどを調査しております。

イントロダクション

エグゼクティブ・サマリー

臨床化学・免疫診断検査(全30種)

内分泌機能検査(全13種)

治療薬物モニタリング検査(TDM)(全11種)

免疫タンパク検定(全2種)

薬物濫用(全12種)

化学・免疫検査用解析装置(全15社分)

現在・将来の技術

  • モノクローナル抗体
  • 疫学的検定
  • ドライケミストリー
  • バイオセンサー
  • IT・自動化
  • 分子診断

米国市場

  • 市場概況
    • ビジネス環境
    • 市場構造
  • 開業医・グループ診断
  • 補助的医療施設
  • がんクリニック
  • 外来治療センター
  • 外科手術センター
  • 介護施設
  • 産院
  • 主要サプライヤーの売上高・市場シェア

ドイツ市場

  • ビジネス環境
  • 市場構造
  • 市場概況
  • 検査件数・売上高予測
  • 主要サプライヤーの売上高・市場シェア

スペイン市場

  • ビジネス環境
  • 市場構造
  • 市場概況
  • 検査件数・売上高予測
  • 主要サプライヤーの売上高・市場シェア

主要製品の開発機会

  • ルーチン・特殊化学検査
  • 微生物/感染症検査
  • 血液検査・フローサイトメトリー
  • 血液凝固検査

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業プロファイル

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • 栄研化学
  • 富士レビオ/Innogenetics
  • Grifols
  • Instrumentation Laboratory
  • 協和メデックス
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • シスメックス
  • Thermo Fisher
  • 東ソー
  • 和光純薬工業
  • Wallac/PE

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPPOC17416

VPGMarketResearch’s new report provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:
Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Routine Clinical Chemistry Tests

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes (Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine,   GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.

Endocrine Function Tests

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.

Therapeutic Drug Monitoring (TDM) Tests

Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Immunoprotein Tests

C3, C4, CRP, IgA, IgE Specific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies, and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - ADI/American Diagnostica    - Agilent Technologies    - Alere/Biosite/Inverness    - Axis-Shield    - Beckman Coulter/Danaher    - Becton Dickinson    - Bio/Data    - Biomerieux    - Bio-Rad    - Cepheid    - Chrono-Log    - Corgenix    - Decode Genetics    - Diadexus    - Diagnocure    - Diagnostica Stago/Trinity Biotech    - Diamedix/Erba    - Diasorin    - Eiken Chemical    - EKF Diagnostics    - Fujirebio    - Grifols    - Helena Laboratories    - Hologic/Gen-Probe    - Horiba    - Instrumentation Laboratory    - International Technidyne/Nexus DX    - Kreatech/Leica    - Kyowa Medex    - Lonza    - Mackay Life Sciences    - Matritech    - Nihon Kohden    - Ortho-Clinical Diagnostics    - Polartechnics    - Polymedco    - Qiagen    - Roche    - SDIX    - Sequenom    - Siemens    - Sienco    - Sysmex    - Takara Bio    - ThermoFisher    - Tosoh    - Wako    - Zycare/Alere

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 500 pages and 129 tables

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Review of Clinical Chemistry Immunodiagnostic Tests

  • 1. Albumin
  • 2. Alkaline Phosphatase
  • 3. ALT/SGPT
  • 4. Ammonia
  • 5. Amylase
  • 6. AST/SGOT
  • 7. Bilirubin
  • 8. Blood Gases
  • 9. Blood Urea Nitrogen (BUN)
  • 10. Calcium
  • 11. Cholesterol
  • 12. Cholinesterase
  • 13. Creatinine
  • 14. Electrolytes
    • a. Carbon Dioxide/Bicarbonate
    • b. Chloride
    • c. Potassium
    • d. Sodium
  • 15. Ferritin
  • 16. Follate/Folic Acid
  • 17. Fructosamine
  • 18. Gamma-Glutamyl Transpeptidase (GGT)
  • 19. Glucose
  • 20. High Density Lipoprotein (HDL)
  • 21. Iron
  • 22. Lactate Dehydrogenase (LDH)
  • 23. Magnesium
  • 24. Phosphorus
  • 25. Protein
  • 26. Triglycerides
  • 27. Troponin
  • 28. Uric Acid
  • 29. Urinalysis
  • 30. Vitamin B12

Endocrine Function Tests

  • 1. Cortisol
  • 2. Follicle-Stimulating Hormone (FSH)
  • 3. Gastrin
  • 4. Human Chorionic Gonadotropin (HCG)
  • 5. LH
  • 6. Prolactin
  • 7. T3
  • 8. T3 Uptake
  • 9. Free T3
  • 10. Thyroxine (T4)
  • 11. Free T4
  • 12. TBG
  • 13. TSH

Therapeutic Drug Monitoring (TDM)

  • 1. Overview
  • 2. Carbamazepine
  • 3. Digoxin
  • 4. Gentamicin
  • 5. Lidocaine
  • 6. Lithium
  • 7. Phenytoin/Dilantin
  • 8. Procainamide
  • 9. Quinidine
  • 10. Theophylline
  • 11. Valproic Acid

Immunoprotein Tests

  • 1. CRP
  • 2. Immunoglobulins

Drugs of Abuse

  • 1. Overview
  • 2. Test Methodologies
  • 3. Amphetamines
  • 4. Barbiturates
  • 5. Benzodiazepines
  • 6. Cannabinoids/Marijuana
  • 7. Cocaine
  • 8. Lysergic Acid Diethylamide (LSD)
  • 9. Methadone
  • 10. Methaqualone
  • 11. Opiates
  • 12. Phencyclidine

Instrumentation: Chemistry Immunodiagnostic Analyzers Manufactured by:

  • Abaxis
  • Abbott
  • Alfa Wassermann
  • Awareness Technologies
  • Beckman Coulter/Danaher
  • bioMeriuex
  • Carolina Chemistries
  • Horiba
  • Inverness
  • Medica
  • Nova Biomedical
  • Ortho-Clinical Diagnostics
  • Polimedco
  • Randox
  • Roche

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • c. Fluorescent Immunoassays
      • Fluorescent Polarization
      • Time-Resolved Pulse Fluorescence
    • d. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

U.S.A.

A. Market Overview

  • 1. Business Environment
    • a. Health Care Expenditures
    • b. Cost Consciousness
    • c. Reimbursement
    • d. Industry Consolidation
    • e. Managed Care
      • PPO
      • HMO
    • f. Hospitals
    • g. Admissions
    • h. Length of Stay
    • i. Industry Diversification
    • j. Physician Demographics
    • k. Aging Population
      • More Chronic Illness
      • Disease Incidence
      • Susceptibility to latrogenesis
      • Multiple Illnesses Cases
    • l. Laboratory Regulations
  • 2. Market Structure
    • a. Hospitals
    • b. Commercial/Private Laboratories

B. Physician Offices/Group Practices

  • 1. Market Summary
  • 2. Market Structure
  • 3. Test Volume and Sales Forecasts

C. Ancillary Hospital Locations

  • 1. Introduction
    • a. Emergency Departments
    • b. Operating Suites
    • c. Intensive Care Units
  • 2. Emergency Departments
    • a. Market Summary
    • b. Test volume and Sales Forecasts
  • 3. Operating and Recovery Suites
    • a. Market Summary
    • b. Test Volume and Sales Forecasts
  • 4. ICUs/CCUs
    • a. Market Summary
    • b. Test Volume and Sales Forecasts

D. Cancer Clinics

  • 1. Introduction
  • 2. Market Summary
  • 3. Test Volume and Sales Forecasts

E. Ambulatory Care Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

F. Surgery Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

G. Nursing Homes

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

H. Birth Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

I. Major Suppliers' Sales and Market Shares

Germany

  • A. Market Overview
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Sales and Market Shares

Spain

  • A. Business Environment
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Sales and Market Shares

Major Product Development Opportunities

  • A. Routine and Special Chemistry
  • B. Microbiology/Infectious Diseases
  • C. Hematology and Flow Cytometry
  • D. Coagulation

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio/Innogenetics
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin/Dilantin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Immunoprotien Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Tumor Markers Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Immunoprotein Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices TDM Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Endocrine Function Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Immunoprotein Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital ICUs/CCUs Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Reagent Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Instrument Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Cancer Clinics Endocrine Function Test Volume Forecast
  • U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Cancer Clinics Endocrine Function Reagent Market Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Surgery Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Nursing Homes Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Birth Centers Profiles, Panels and Individual Tests
  • U.S.A., Birth Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
  • Germany, Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
  • Germany, Physician Offices/Group Practices Endocrine Function Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecast
  • Germany, Physician Offices/Group Practices Immunoprotein Test Volume Forecast
  • Germany, Physician Offices/Group Practices TDM Test Volume Forecast
  • Germany, Physician Offices/Group Practices Routine Chemistry Reagent Market Forecast
  • Germany, Physician Offices/Group Practices Cancer Diagnostics Market Forecast by Test
  • Germany, Physician Offices/Group Practices Endocrine Function Diagnostics Market Forecast
  • Germany, Physician Offices/Group Practices TDM Reagent Market Forecast
  • Germany, Physician Offices/Group Practices Immunoprotein Reagent Market Forecast
  • Germany, Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast
  • Germany, Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
  • Germany, Major Suppliers of Clinical Chemistry Reagent Estimated Market Shares
  • Germany, Major Suppliers of Clinical Chemistry Analyzers Estimated Market Shares
  • Germany, Major Suppliers of Immunodiagnostic Products Estimated Market Shares
  • Germany, Major Suppliers of Immunodiagnostic Reagent Estimated Market Shares
  • Germany, Major Suppliers of Immunoassay Analyzers Estimated Market Shares
  • Spain, Laboratory Performing Chemistry and Immunoassay Tests Forecast by Market Segment
  • Spain, Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
  • Spain, Ambulatory Care Centers Endocrine Function Test Volume Forecast
  • Spain, Ambulatory Care Centers TDM Test Volume Forecast
  • Spain, Ambulatory Care Centers Immunoprotein Test Volume Forecast
  • Spain, Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
  • Spain, Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast
  • Spain, Ambulatory Care Centers Endocrine Function Reagent Market Forecast
  • Spain, Ambulatory Care Centers TDM Reagent Market Forecast
  • Spain, Ambulatory Care Centers Immunoprotein Reagent Market Forecast
  • Spain, Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast
  • Spain, Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
  • Spain, Major Suppliers of Immunodiagnostics Products Estimated Market Shares
Back to Top